_______________________________________________________________________________ FORM 10-Q/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________ (Mark One) [X] AMENDMENT NO. 1 to QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 1994 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-6639 CHARTER MEDICAL CORPORATION (Exact name of Registrant as specified in its charter) Delaware 58-1076937 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 3414 Peachtree Rd., NE, Suite 1400 Atlanta, Georgia 30326 (Address of principal executive offices) (Zip Code) (404) 841-9200 (Registrant's telephone number, including area code) See Table of Additional Registrants below. ___________ Not Applicable (Former name, former address and former fiscal year, if changed since last report) ___________ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes X No The number of shares of the Registrant's Common Stock outstanding as of January 31, 1995, was 28,341,246. _______________________________________________________________________________ FORM 10-Q/A CHARTER MEDICAL CORPORATION AND SUBSIDIARIES PART II - OTHER INFORMATION The Registrant hereby amends the Quarterly Report on Form 10-Q for the quarter ended December 31, 1994 by adding to Item 6(a) a Financial Data Schedule as Exhibit 27. Item 6. - Exhibits and Reports on Form 8-K (a) Exhibits 4(a) Amendment No. 3, dated as of December 12, 1994, to Second Amended and Restated Credit Agreement, dated as of May 2, 1994, among the Company, the financial institutions listed therein, Bankers Trust Company, as Agent, and First Union National Bank of North Carolina, as Co-Agent. 4(b) Amendment No. 4, dated as of January 11, 1995, to Second Amended and Restated Credit Agreement, dated as of May 2, 1994, among the Company, the financial institutions listed therein, Bankers Trust Company, as Agent, and First Union National Bank of North Carolina, as Co-Agent. 4(c) Indenture Supplement No. 1, dated June 3, 1994, among the Company, the Guarantors listed therein and Marine Midland Bank, as Trustee, relating to the 11.25% Senior Subordinated Notes due April 15, 2004, together with a schedule identifying substantially similar documents, pursuant to Instruction 2 to Item 601 of Regulation S-K. 27 Financial Data Schedule. (b) Report on Form 8-K On December 15, 1994, the Company filed a Form 8-K dated November 30, 1994 disclosing the acquisition of substantially all the assets of 10 behavioral healthcare facilities from National Medical Enterprises, Inc. FORM 10-Q/A CHARTER MEDICAL CORPORATION AND SUBSIDIARIES SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarter ended December 31, 1994 to be signed on its behalf by the undersigned thereunto duly authorized. CHARTER MEDICAL CORPORATION (Registrant) Date: March 14, 1995 /s/ Lawrence W. Drinkard Lawrence W. Drinkard Executive Vice President - Finance (Chief Financial Officer) Date: March 14, 1995 /s/ John R. Day John R. Day Vice President and Controller (Principal Accounting Officer)